Cargando…

Osteonectin as a screening marker for pancreatic cancer: A prospective study

OBJECTIVE: Osteonectin plays a central role in various processes during the development of pancreatic adenocarcinoma. This prospective pilot study was performed to determine the feasibility of serum osteonectin as a screening tool for pancreatic cancer. METHODS: Blood samples were collected from 15...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papapanagiotou, Angeliki, Sgourakis, George, Karkoulias, Kyriakos, Raptis, Dimitris, Parkin, Edward, Brotzakis, Pantelis, Panchal, Sanjay, Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124255/ https://www.ncbi.nlm.nih.gov/pubmed/29756486 http://dx.doi.org/10.1177/0300060518772413

Ejemplares similares

Expression of osteopontin and osteonectin in breast cancer.
por: Kim, Y. W., et al.
Publicado: (1998)

Osteonectin bidirectionally regulates osteoblast mineralization
por: Zhu, Yun‑Sen, et al.
Publicado: (2023)

Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling
por: Delany, Anne M., et al.
Publicado: (2009)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2015)

Osteocalcin and osteonectin expression after double application of platelet-rich plasma in rabbits
por: Ozdemir, Burcu, et al.
Publicado: (2016)

Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
Publicado: (1988)

In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization
Publicado: (1987)

Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40)
por: Basu, Amitabha, et al.
Publicado: (2001)

Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate
Publicado: (1995)

Expression Analysis of SPARC/Osteonectin in Oral Squamous Cell Carcinoma Patients: From Saliva to Surgical Specimen
por: Aquino, Gabriella, et al.
Publicado: (2013)

Circulating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMS
por: Fu, Junling, et al.
Publicado: (2018)

AT1 and AT2 Receptor Knockout Changed Osteonectin and Bone Density in Mice in Periodontal Inflammation Experimental Model
por: Lima, Maria Laura de Souza, et al.
Publicado: (2021)

Regulation of the Fibrosis and Angiogenesis Promoter SPARC/Osteonectin in Human Adipose Tissue by Weight Change, Leptin, Insulin, and Glucose
por: Kos, Katrina, et al.
Publicado: (2009)

The Effect of Adiponectin on Osteonectin Gene Expression by Oxidized Low Density Lipoprotein-Treated Vascular Smooth Muscle Cells
por: Niknam, Sara, et al.
Publicado: (2015)

Discoidin domain receptor 2 activation of p38 mitogen-activated protein kinase as an important pathway for osteonectin-regulating osteoblast mineralization
por: Zhu, Yun-Sen, et al.
Publicado: (2021)

Appearance of Osteonectin‐expressing Fibroblastic Cells in Early Rat Stomach Carcinogenesis and Stomach Tumors Induced with N‐Methyl‐N′‐nitro‐N‐nitrosoguanidine
por: Maeng, Hack‐Young, et al.
Publicado: (2002)

Upregulation of IL‐8, osteonectin, and myonectin mRNAs by intermittent hypoxia via OCT1‐ and NRF2‐mediated mechanisms in skeletal muscle cells
por: Takasawa, Shin, et al.
Publicado: (2022)

The Impact of Educational Status on the Postoperative Perception of Pain
por: Lanitis, Sophocles, et al.
Publicado: (2015)

Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40
por: DAUGAARD, SØREN, et al.
Publicado: (2009)

Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter–Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth
por: Sung, Shian-Ying, et al.
Publicado: (2016)

Management of patients after recovering from acute severe biliary pancreatitis
por: Dedemadi, Georgia, et al.
Publicado: (2016)

Expression of Stemness Markers in the Cervical Smear of Patients with Cervical Insufficiency
por: Pittokopitou, Savvia, et al.
Publicado: (2023)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

Malignant circuits: Novel therapeutic opportunities in neuro‐oncology
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Pancreatitis of the Gastroduodenal Groove: A Case Report
por: German, Vasileios, et al.
Publicado: (2010)

Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
por: Poulia, Kalliopi Anna, et al.
Publicado: (2020)

Guide for determination of protein structural ensembles by combining cryo‐EM data with metadynamics
por: Brotzakis, Z. Faidon
Publicado: (2023)

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
por: Piperi, Christina, et al.
Publicado: (2019)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

A method for the prediction of GPCRs coupling specificity to G-proteins using refined profile Hidden Markov Models
por: Sgourakis, Nikolaos G, et al.
Publicado: (2005)

Prevalence and Prognostic Factors of Stress Hyperglycemia in a Pediatric Population with Acute Illness in Greece—A Prospective Observational Study
por: Korakas, Emmanouil, et al.
Publicado: (2022)

Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?
por: Kassi, Eva N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ne3nb3rlduam363mu04juo17uk